May Ann Lee
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
-
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
-
- Cancer-related gene regulation 5
- Wnt/β-catenin signaling in development and cancer 5
- RNA modifications and cancer 3
- Oncology 10
- Peptidase Inhibition and Analysis 3
- Cancer-related Molecular Pathways 2
- Co-authors
- David M. Virshup (8 shared papers)Babita Madan (8 shared papers)Zhiyuan Ke (7 shared papers)Vishal Pendharkar (5 shared papers)Rami N. Hannoush (1 shared paper)Lijun Ding (1 shared paper)Kyle David Proffitt (1 shared paper)Meng Ling Choong (7 shared papers)
- Journals
- Journal of Medicinal Chemistry (2 papers)Cancer Research (2 papers)Cell Cycle (2 papers)Journal of Clinical Oncology (1 paper)Cancer Cell International (1 paper)
- Partner nations
- SingaporeUnited StatesBelgium
In The Last Decade
May Ann Lee
24 papers receiving 889 citations
Peers
Comparison fields: 5 of 86
- Oncology 223
- Molecular Biology 597
- Genetics 51
- Hematology 41
- Cancer Research 50
Countries citing papers authored by May Ann Lee
This map shows the geographic impact of May Ann Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Ann Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Ann Lee more than expected).
Fields of papers citing papers by May Ann Lee
This network shows the impact of papers produced by May Ann Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Ann Lee. The network helps show where May Ann Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside May Ann Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 314 | |
| 2 | 2009 | 110 | |
| 3 | 2019 | 66 | |
| 4 | 2013 | 46 | |
| 5 | 2004 | 46 | |
| 6 | 2015 | 33 | |
| 7 | 2021 | 32 | |
| 8 | 2005 | 30 | |
| 9 | 2017 | 29 | |
| 10 | 2017 | 28 | |
| 11 | 2015 | 25 | |
| 12 | 2009 | 25 | |
| 13 | 2008 | 21 | |
| 14 | 2016 | 21 | |
| 15 | 2001 | 19 | |
| 16 | 2015 | 19 | |
| 17 | 2005 | 15 | |
| 18 | 2014 | 10 | |
| 19 | 2012 | 4 | |
| 20 | 2024 | 4 |
About May Ann Lee
May Ann Lee is a scholar working on Molecular Biology, Oncology, Epidemiology, Infectious Diseases and Small Animals, having authored 25 papers that have together received 902 indexed citations. Recurring topics across this work include Cancer-related gene regulation (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Burkholderia infections and melioidosis (3 papers), Peptidase Inhibition and Analysis (3 papers), RNA modifications and cancer (3 papers), Brucella: diagnosis, epidemiology, treatment (2 papers), Cancer-related Molecular Pathways (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (223 citations), Molecular Biology (597 citations), Genetics (51 citations), Hematology (41 citations) and Cancer Research (50 citations). May Ann Lee has collaborated with scholars based in Singapore, United States and Belgium. Frequent co-authors include David M. Virshup, Babita Madan, Zhiyuan Ke, Vishal Pendharkar, Rami N. Hannoush, Lijun Ding, Kyle David Proffitt, Meng Ling Choong, David P. Lane and Henry C. Yang. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, Cell Cycle, Journal of Clinical Oncology and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.